Skip to main content

Find Clinical Trials

Home
Conditions
Hepatocellular Carcinoma (HCC)

Clinical trial condition

Hepatocellular Carcinoma (HCC)

Explore clinical trials studying Hepatocellular Carcinoma (HCC). Study availability and eligibility vary by location and protocol.

230 public trials 90 recruiting studies

Refine in advanced search Browse all conditions

Hepatocellular Carcinoma (HCC) trial results

Not Yet Recruiting

Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

NCT07636148

Conditions: Adenocarcinoma, Bone Cancer Metastatic, Bone Cancer Tumor, +46 more
Locations: Hospices Civils de Lyon - Hôpital Édouard Herriot Lyon, Auvergne-Rhône-Alpes, France

Assistance Publique Hopitaux de Paris - Hôpital Henri Mondor Créteil, Île-de-France Region, France

Leiden University Medical Center Leiden, South Holland, Netherlands

View Trial Details

Not Yet Recruiting

Liver Transplant for Hepatocellular Carcinoma

NCT07629193

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study

NCT07620574

Conditions: Adenocarcinoma, Cancer, Carcinoma, +39 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Lenvatinib or Regorafenib for Advanced Hepatocellular Carcinoma After Immunotherapy (REVIVE)

NCT07495579

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Not Yet Recruiting

68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma

NCT07590336

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Peking Union Medical College Hospital Beijing, China

View Trial Details

Not Yet Recruiting

A Phase 1 First-in-Human Study of CRPA1A2, a MAGE-A1/HLA-A*02:01 Bispecific T-Cell Engager, in Patients With Solid Tumors

NCT07583316

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +26 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Hybrid Deep Learning Integrating Multimodal CEUS and Enhanced MRI to Optimize Early-Stage HCC Treatment Decisions

NCT07582419

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The First Hospital of jilin University Changchun, Jilin, China

View Trial Details

Not Yet Recruiting

Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy

NCT07565415

Conditions: Adenocarcinoma, Anorexia, Body Weight, +21 more
Locations: Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Efficacy and Safety of Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy (TACE-HAIC) as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Single-arm Phase 2 Trial

NCT07543783

Conditions: Adebrelimab (SHR-1316), Adenocarcinoma, Bevacizumab, +11 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis

NCT07544121

Conditions: Adenocarcinoma, Blood-Borne Infections, Carcinoma, +28 more
Locations: Not specified

View Trial Details